|
|
|
Mutation Rate in European descendant (%) |
Mutation Rate in
African descendant (%) |
Reference |
BRCA 2
|
x
|
PARPi
|
4.45%
10.02%
|
4.23%
9.73%
|
Kamran et al.69
Koga et al. 67
|
ATM
|
x
|
PARPi
|
7.29%
5.75%
|
9.86%
3.78%
|
Kamran et al.69
Koga et al. 67
|
PALB2 |
x |
|
0.83% |
2.16% |
Koga et al.
67
|
CHECK2 |
x |
PARPi |
2.32% |
1.08% |
Koga et al.
67
|
MSH2 |
x |
Checkpoint Inhibitor |
1.30% |
1.62% |
Koga et al.
67
|
MSH6 |
x |
Checkpoint Inhibitor |
1.76% |
1.08% |
Koga et al.
67
|
FANCA |
x |
PARPi |
1.11% |
0.00% |
Koga et al.
67
|
NBN |
x |
PARPi |
0.65% |
1.08% |
Koga et al.
67
|
CDK12 (somatic only)
|
|
Checkpoint Inhibitor
|
5.55%
4.73%
|
11.27%
7.57%
|
Kamran et al.69
Koga et al. 67
|